Black men often have a higher level of a type of immune cell called plasma cells in their tumors than do white men. These cells might drive a better response to immunotherapy.
Lower PSA Yields Longer Survival with Provenge Treatment
Provenge When Used In Castrate Sensitive Men with Prostate Cancer Changes PSA Kinetics, But Does Not Effect Time To Bio-Chemical Failure
The understanding that the earlier Provenge is used in castrate resistant men with prostate cancer has led many men to ask why not use Provenge even earlier when they are still castrate sensitive? This question is an excellent one which follows the logical next step; however, the answer is surprising!
